The purpose of this study is to report on five cases treated with bone graft using recombinant human bone morphogenetic protein-2 (rhBMP-2) on jaw defects after cyst enucleation. We performed bone graft with BMP (rhBMP-2+β-tricalcium phosphate/hydroxyapatite) wrapped with a collagen sponge on jaw defects after cyst enucleation. Postoperative panoramic radiographs were taken periodically. After 1 to 12 months, bone remodeling was observed in the jaw defect area. In our cases, there were few signs or symptoms of recurrence of the cyst during the follow-up period.
Introduction
Odontogenic cysts in the oral and maxillofacial region are divided into developmental cysts which have no clear cause for occurrence, and inflammatory cysts associated with the inflammatory process. While periapical cyst, residual cyst, and periodontal cyst, and so on are inflammatory, dentigerous cyst, odontogenic keratocyst, calcifying odontogenic cyst, lateral periodontal cyst, glandular odontogenic cyst, and so on are developmental. Most cysts in the jawbone are odontogenic cysts, and periapical cyst is the most commonly occurring cyst (65%), followed by dentigerous cyst and odontogenic keratocyst [1] [2] [3] . Among them, odontogenic keratocyst and calcifying odontogenic cyst are classified according to benign neoplasms rather than kinds of cysts, due to their high recurrence rate and aggressive properties.
Cyst decompression or cyst enucleation is commonly employed as a treatment for odontogenic cysts.
For cyst enucleation, a bone graft into the bony defects after enucleation is preferred; however, satisfactory healing without a bone graft, depending on the conditions of the cyst, has commonly been observed. The size and location of the cyst, impacted tooth, the amount and state of surrounding bones, soft tissue defect, patient's performance status, preoperative inflammatory condition, and periapical lesion are known to affect healing of cysts.
In general, in the case of a large cyst, it is difficult to 
Case Report
For five patients (three males and two females), cyst enucleation and rhBMP-2 loaded bone graft were implemented under general anesthesia, and they were monitored for one to twelve months after the operation ( Table   1 , Fig. 1∼5 ).
Under general anesthesia, the lesion was removed and apicoectomy was performed after extraction of the asso- A summary of the details of each case is shown in Table 1 .
Discussion
Cyst enucleation leads to development of defects in the jawbone, and, in this case, a bone graft may be planned in order to improve healing of the bone defects. A bone graft after cyst enucleation is preferred by some surgeons, as it is favorable to bone regeneration and decreases the possibility that even spontaneous healing occurs, it is not However, spontaneous healing is limited in bone defects over a certain size; this is called a critical size defect. This is mainly studied in animal experiments. In particular, it is known that a rabbits' cranium is larger than 15 mm [5] , and bone defects over 8 mm in the dogs' mandible are known not to show spontaneously healing [6] . In fact, because practical clinical situations are influenced by a large number of factors, it is difficult to determine the critical size defect for humans. In this study, a bone graft using a synthetic bone was combined, because most cysts were over 2 cm, and it was considered that a complete recovery of bony defects with spontaneous healing only was difficult to anticipate.
Materials used for bone graft include autogenous bone
graft, allograft, xenograft, and synthograft, and, quite recently, platelet-rich plasma (PRP) and rhBMP-2 have also been used in promotion of osteogenesis [7] . As a synthograft, HA and β-TCP are used most often, and β-TCP, an absorptive ceramic particle, is a synthetic biomaterial used frequently as a substrate for bone regeneration and augmentation in the oral and maxillofacial region. Ogose et al. [8] suggested that porous β-TCP is a biodegradable material with excellent osteoconductivity and clinical efficiency. In addition, the porous structure of β-TCP plays a role as scaffold for BMP or PRP. Urist [9] discovered BMP while investigating substrates for osteoinduction. As a kind of transforming growth factor β group, this protein is preserved in various tissues for a long time, and has multiple functions, such as embryogenesis, homeostasis maintenance, and healing inside the tissue, or while tissues are being generated. According to the studies reported so far, BMP is also a strong inducer of osteogenesis and osteoblasts [10] . In order to promote bone healing, a number of researchers have been making an effort to improve osteoinductive capacity by addition of rhBMP-2 to β-TCP.
After observing bone formation using rhBMP-2 and TCP at various concentrations, Matsushita et al. [11] insisted that rhBMP-2 and β-TCP have osteoinductive capacity and biodegradable properties. In a comparison of two groups using various ratios of HA and TCP in the rabbits' cranium, Alam et al. [12] also reported that a bone formation was observed in the group with rhBMP-2, whereas a fibrous connective tissue was observed in the control group without rhBMP-2. Jingushi et al. [13] observed bone formation when transplanting rhBMP-2 and β-TCP in rabbits' muscle.
BMP used in this research is rhBMP-2, which was freeze-dried on the surface of β-TCP, and here, β-TCP works as a scaffold of rhBMP-2. Use of a collagen sponge along with BMP is thought not only to play a role as a membrane to prevent grown soft tissues from coming in contact with rhBMP-2 but also to help to fix a graft material firmly by filling the remaining space of wide bony defects.
A bone graft into bony defects after cyst enucleation relies heavily on surgeons' preferences, and a standard treatment protocol has not been established. Most of the five cases described in this study had wide bony defects greater than 2 cm, and based on the judgment that complete bone formation could not occur with spontaneous healing only, rhBMP-2 (β-TCP+HA) was transplanted into them using a collagen carrier, and post-operative follow-up showed satisfactory bone formation in the majority of the patients, regardless of age and gender.
Sufficient effect of bone graft was achieved with a relatively small amount of bone graft materials (0.25 to 0.50 g), with realistic cystic size when bone graft materials were transplanted using collagen carriers, compared to the method for filling extensive bony defects with only bone graft material. Although many studies have reported that rhBMP-2 showed higher osteoinductive capacity, it is still more expensive than other graft materials, including allografts and xenografts, and this problem requires significant improvement.
In addition, in most cases, bone formation was completed within one year; however, it is difficult to be certain that this indicates significant differences compared to cases in which bone grafts were not performed, and for a more precise evaluation, observation of more cases would be needed in the future.
